Complete androgen blockade: data from an EORTC 30853 trial.
Denis
L
L
Department of Urology, A.Z. Middelheim, Antwerp, Belgium.
Keuppens
F
F
Robinson
M
M
Mahler
C
C
Smith
P
P
Pinto de Carvalho
A P
AP
Newling
D
D
Bono
A
A
Sylvester
R
R
De Pauw
M
M
D000368:Aged; D000813:Anilides / Q000627:therapeutic use*; D002064:Buserelin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005060:Europe; D005485:Flutamide / Q000627:therapeutic use*; D017273:Goserelin; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000401:mortality / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate
D000813:Anilides; D017273:Goserelin; D005485:Flutamide; D002064:Buserelin